Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
about
Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoproteinHypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neuronsBrain Control of Plasma Cholesterol Involves Polysialic Acid Molecules in the Hypothalamus.Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis.Mouse models of the metabolic syndrome.Inhibition of the central melanocortin system decreases brown adipose tissue activityCNR1 genotype influences HDL-cholesterol response to change in dietary fat intakeHepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver.Acute central neuropeptide Y administration increases food intake but does not affect hepatic very low-density lipoprotein (VLDL) production in miceCentral nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervationChallenges and opportunities of defining clinical leptin resistanceCentral effects of humanin on hepatic triglyceride secretion.Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the BrainThe Long Term Kinetic of Plasma Lipids and Lipoproteins in Tyloxapol Injected RatsRole of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance.Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity.Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies.Hypothalamic control of energy metabolism via the autonomic nervous system.Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Hypothalamic control of lipid metabolism: focus on leptin, ghrelin and melanocortins.CNS regulation of plasma cholesterol.Insulin and glucagon signaling in the central nervous system.Autonomic regulation of hepatic glucose production.iNOS promotes hypothalamic insulin resistance associated with deregulation of energy balance and obesity in rodents.Hypertriglyceridemia in female rats during pregnancy induces obesity in male offspring via altering hypothalamic leptin signaling.Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system.A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins.
P2860
Q28583188-AF875015-A09B-4BEF-9D02-6611F9944696Q33600513-77318695-EAAF-492C-91CC-F93E69F82F85Q33630983-EF1A8060-B331-4139-8096-2BD2059DEA17Q33765662-173EC288-F7CB-4FE4-A490-C571F13F7B2FQ33849244-689561F3-0D4A-401C-A748-67EE5776B17DQ34238637-677C4F82-E6BD-4AF0-A57A-3EA2E07903B5Q34261731-C8C7C9DF-9831-4A48-BDC2-B1609C7FBECCQ34526978-F4FA207F-0A6E-49B1-BAA0-24860A977539Q34608233-844CDC57-B920-4C40-963B-8169B221C600Q35113488-6C76D629-6385-42F9-A2F6-55CB568B0492Q35762785-009D3261-E7FE-44BA-952A-D9C785AF6CF0Q35916831-1BD3C53D-890B-4D30-AF4D-3F447D009F89Q36494405-2B613563-7273-4C8F-8504-8293FE5786B7Q36930787-ED140148-23F4-4EDA-A4DB-2D646BD8E97BQ37132426-53ADC267-E8A5-4BD4-BA68-853A2279630CQ37342440-1D5F8FCC-3807-4D0C-9046-AEE20B585235Q37394350-5084DFA2-C957-4CB7-B454-DF7DE6B00FF5Q37457206-EEEECD96-BBFD-403A-A39C-913AB4BE6AE3Q37808731-656FF844-945C-4F94-A970-0E19E651CF91Q37831911-D85CC0F4-E6DD-4EEC-BECF-81B8CEC39E8DQ37876093-50CF1808-93A7-4A22-8924-7BBADEFEB112Q37897218-9B6E73C6-EB8F-44D7-9B9C-6F3A07E0F949Q38130123-69F5167A-D216-449F-82ED-78D50A460319Q38318620-027563A9-6869-4829-B595-2B65037C29B1Q41504405-7B798763-89E4-4746-906C-2D7226C25329Q41593214-D0895D77-B8ED-438C-9BDB-A6CA028ECC3AQ41941977-F6D6D756-AC4D-4F85-A8A9-F367F25AD872Q42175219-01D44D62-3216-4362-80E6-08B2654648DC
P2860
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
@en
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
@nl
type
label
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
@en
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
@nl
prefLabel
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
@en
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
@nl
P2093
P2860
P356
P1433
P1476
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion
@en
P2093
John M Stafford
Kevin D Niswender
Larry L Swift
Richard Printz
P2860
P304
P356
10.2337/DB07-1702
P407
P577
2008-03-10T00:00:00Z